CARY, N.C., Feb. 08, 2017 -- Arysta LifeScience recently announced that it has entered into a global collaboration with DuPont Crop Protection for the development of new foliar insecticides based on the market-leading product, DuPont™ Rynaxypyr® (chlorantraniliprole). The long-term agreement between the two companies allows Arysta LifeScience to combine Rynaxypyr® insect control in premixes with acetamiprid, thereby creating novel insecticidal formulations that more efficiently and conveniently address needs of growers.
“Through our collaboration with DuPont, we are expanding our development of proprietary foliar insecticides for specialty crop protection,” said Diego Lopez Casanello, president, Arysta LifeScience. “The premix formulations will control a broader spectrum of pests than straight Rynaxypyr® products, which will increase its utility to growers in many countries around the world.”
“Our agreement with Arysta LifeScience increases the value of our investment in Rynaxypyr®, and most importantly, gives growers more tools to effectively manage insects,” said Timothy P. Glenn, president, DuPont Crop Protection.
Combining Rynaxypyr® with acetamiprid offers multiple benefits including:
- Broadening the spectrum of control of Rynaxypyr® with activity on sucking pests such as whiteflies, aphids, certain lepidoptera, and micro-lepidoptera
- Fit with a broad range of crop segments, including both row and specialty crops
- Offering flexible application timing suitable for integrated pest management
- Controlling pests that have become resistant to other products
About Arysta LifeScience
Arysta LifeScience is a global agricultural company specializing in the marketing and distribution of innovative crop protection and life science brands. With more than 200 active ingredients, Arysta LifeScience has a well-integrated biological and chemical portfolio to provide complete solutions to growers. The company’s wide range of offerings includes biosolutions, fungicides, herbicides, insecticides and seed treatments. Arysta LifeScience, which has more than 4,000 employees working in over 100 countries to serve customers worldwide, had 2015 revenues of US$1.8 billion. Arysta LifeScience is owned by Platform Specialty Products (www.platformspecialtyproducts.com), a global innovator of technologically advanced specialty chemical products and provider of technical services. For more information on Arysta LifeScience, visit www.arystalifescience.com.
Media Contact: Carey Dorman Director – Corporate Development Platform Specialty Products Corporation 1-561-406-8465


Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
OpenAI Addresses Security Vulnerability in macOS App Certification Process
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



